Anaplastic thyroid cancer: Pathogenesis, prognostic factors and genetic landscape (Review)
Molecular and Clinical Oncology · 02.11.2023 · 19 (6)
DOI: 10.3892/mco.2023.2695 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular and Clinical Oncology, online erschienen am 02.11.2023. Verfasst von Abdul-Mohsen G Alhejaily und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, King Fahad Medical City, Riyadh Second Health Cluster, Riyadh 11525, Kingdom of Saudi Arabia. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine, King Fahad Medical City, Riyadh Second Health Cluster, Riyadh 11525, Kingdom of Saudi Arabia.
- Obesity, Endocrine and Metabolism Center, King Fahad Medical City, Riyadh Second Health Cluster, Riyadh 11525, Kingdom of Saudi Arabia.
- Department of Pathology, King Fahad Medical City, Riyadh Second Health Cluster, Riyadh 11525, Kingdom of Saudi Arabia.
Zitieren
APA
Alhejaily, A. G., Alhuzim, O., & Alwelaie, Y. (2023). Anaplastic thyroid cancer: Pathogenesis, prognostic factors and genetic landscape (Review). Molecular and Clinical Oncology, 19(6). https://doi.org/10.3892/mco.2023.2695
Vancouver
Alhejaily AG, Alhuzim O, Alwelaie Y. Anaplastic thyroid cancer: Pathogenesis, prognostic factors and genetic landscape (Review). Molecular and Clinical Oncology. 2023;19(6). doi:10.3892/mco.2023.2695
BibTeX
@article{Alhejaily2023,
author = {Alhejaily, Abdul-Mohsen G and Alhuzim, Omar and Alwelaie, Yazeed},
title = {Anaplastic thyroid cancer: Pathogenesis, prognostic factors and genetic landscape (Review)},
journal = {Molecular and Clinical Oncology},
year = {2023},
volume = {19},
number = {6},
doi = {10.3892/mco.2023.2695}
}
EUVIMED